INTERNATIONAL PATENT: ELPIS BIOPHARMACEUTICALS FILES APPLICATION FOR "CHIMERIC ANTIGEN RECEPTOR TARGETING INTERLEUKIN- 13 RECEPTOR SUBUNIT ALPHA-2 AND OPTIONALLY B7H3 FOR TREATING GLIOBLASTOMA"

GENEVA, March 11 -- ELPIS BIOPHARMACEUTICALS (128 Spring StreetLexington, Massachusetts 02421) filed a patent application (PCT/US2025/044182) for "CHIMERIC ANTIGEN RECEPTOR TARGETING INTERLEUKIN- 13 RECEPTOR SUBUNIT ALPHA-2 AND OPTIONALLY B7H3 FOR TREATING GLIOBLASTOMA" on Aug 29, 2025. With publication no. WO/2026/050637, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Yan (c/o Elpis Biopharmaceuticals128 Spring StreetLexington, Massachusetts 02421), ZHANG, Keming (c/o Elpis Biopharmaceuticals128 Spring StreetLexin...